BRISTOL-MYERS SQUIBB MERGER: GELB AND FURLAUD's LEGACY WILL BE $ 8.6 BIL. COMBO WITH STRATEGIC FIT, CRITICAL MASS, OTCs, AND SUSTAINABLE R&D PIPELINE